JDS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Dairy Science Vol. 51 No. 8 1284-1287
© 1968 by American Dairy Science Association ®
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Menge, A. C.
Right arrow Articles by Christian, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Menge, A. C.
Right arrow Articles by Christian, J. J., Jr.

Estrus Synchronization in Cattle Following Feeding Six Progestogens1

A. C. Menge2 and J. J. Christian, Jr.

Department of Animal Sciences, New Jersey Agricultural Experiment Station, Sussex

ABSTRACT

The oral effectiveness of six progestogens in synchronizing estrus was determined in dairy heifers. The hormones were fed in a concentrate ration twice daily for 17 or 18 days. Four progestogens effectively synchronized estrous cycles at the levels studied. Progestogen 1 (6{alpha}-methyl-4-pregnen-17-Ol-one acetate) synchronized estrus at minimum effective levels of 80 and 90 mg daily. Fertility at the synehronized estrus after Progestogen 1 feeding was depressed, as only 24.1% of the heifers conceived compared with conception in 48.5% of the controls at first service. After two services the conception rates were 65.5 and 69.7% for treated and control heifers, respectively. Progestogen 2 (6-methyl-3,5-pregnadien-17 {alpha}-Ol-20-one-3-ß-acetylthioethoxy acetate) was effective in controlling the estrous cycle at 30 mg daily. Increased levels of this compound up to 90 mg daily did not increase the interval to estrus after the end of treatment. The minimum effective doses of Progestogen 3 (3-aza-A-homo-6{alpha}-methyl-4{alpha}-pregnen-17{alpha}-Ol-4-one acetate) and Progestogen 4(6{alpha}-methyl-4-pregnen-17{alpha}-Ol-3,20-dione-3-ethylene thioketal acetate) were 45 and 90 mg daily. Progestogen 5 (6-{alpha}-methyl-4-pregnen-17{alpha}-Ol-3,20-dione-3-oxime acetate) and Progestogen 6 (17{alpha}-ethynyl-19-norandrost-4,6-diene-3-one-17ß-acetate 3-oxime) were ineffective in controlling estrous cycles at the highest levels tested (90 mg).


FOOTNOTES

1 Paper of the Journal Series, New Jersey Agricultural Experiment Station. This investigation was supported in part by funds provided by Johnson and Johnson Company, New Brunswick, New Jersey.

2 Present address: Center for Research in Reproductive Biology, Department of Obstetrics and Gynecology, University of Michigan Medical Center, Ann Arbor.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1968 by the American Dairy Science Association ®.